Home > Insider Trading > Filing (0001415889-18-001643)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1374328	Fitlife Brands Inc.	FTLF	Medicinal Chemicals & Botanical Products (2833)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1643192	Judd Dayton	C/O Fitlife Brands, Inc. 5214 S. 136Th Street Omaha NE 68137	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-11-12	9,500	$0.46	1,128,601	No	4	P	Indirect	By Sudbury Holdings, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Sudbury Holdings, LLC

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Acquisiton	2018-11-13	525	$0.00	1,141,304	$0.46
Common Stock	Warrant	Acquisiton	2018-11-12	342,391	$0.00	342,391	$0.46

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
525	2018-11-13		No	4	P	Indirect
342,391	2018-11-13	2033-11-13	No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	710,715	Direct
Common Stock	44,400	Indirect	By SEP IRA

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 28, 2018.
Shares of the Issuer's Series A Preferred Stock do not expire.
The Reporting Person, through Sudbury Holdings, LLC, purchased 525 units ("Units") for $1,000 per Unit, with each Unit consisting of one share of the Issuer's Series A Preferred Stock, par value $0.01 per share, and a five-year warrant to purchase that number of shares of the Issuer's common stock equal to 30% of the shares of the Issuer's common stock issuable upon conversion of the Series A Preferred purchased by the Reporting Person.